HIF1A and acute myeloid leukemia: Recent evidence confirms that, with the exception of solid tumors such as breast and liver cancer, HIF-1α is also strongly associated with the development and progression as well as chemotherapy resistance and tumor metastasis of hematological malignancies (e.g., acute myeloid leukemia (AML)).11